Comprehensive NGS Profiling to Enable Detection of ALK Gene Rearrangements and MET Amplifications in Non-Small Cell Lung Cancer

Authors:

Sergi Clave´ ^1,2,3, Jennifer B. Jackson⁴, Marta Salido^1,2,3, Jacob Kames4, Kelly M. R. Gerding⁴, Ellen L. Verner⁴,
Eric F. Kong⁴, Elizabeth Weingartner⁴, Joan Gibert², Max Hardy-Werbin^2,5, Pedro Rocha^2,3,5, Xènia Riera^1,2,
Erica Torres¹, James Hernandez⁴, Gustavo Cerqueira⁴, Donna Nichol⁴, John Simmons⁴, A´ lvaro Taus^2,5, Lara Pijuan¹, Beatriz Bellosillo^1,2,3 and Edurne Arriola^2,3,5* 
¹Pathology Department, Hospital del Mar, Barcelona, Spain, ²Cancer Research Program, Hospital del Mar Medical Research Institute, Barcelona, Spain, ³Centro de Investigacio´ n Biome´ dica en Red de Ca´ ncer (CIBERONC), Madrid, Spain, ⁴Personal Genome Diagnostics (PGDx/Labcorp), Baltimore, MD, United States, ⁵Medical Oncology Department, Hospital del Mar, Barcelona, Spain